Momenta, Amphastar Fight Jury Decision In $1B Patent Suit
After a Massachusetts federal jury shot down Momenta Pharmaceuticals and Sandoz Inc.'s $1 billion patent infringement suit against Amphastar Pharmaceuticals, regarding a quality-control test for a generic blood thinner, each of...To view the full article, register now.
Already a subscriber? Click here to view full article